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Summary: The aim of this study was to assess lipid peroxidation in chronic leg ischaemia by determining thiobarbi-
turic acid reactants. Furthermore, Cu, Zn-superoxide dismutase and glutathione peroxidase activities as well as the
trace element profile (Zn, Cu, Se, Mg) were determined. Fasting blood samples from the common femoral artery
and vein were taken from both legs of 15 patients (57 ± 7 years) with peripheral arteriosclerosis and 9 individuals
(54 ± 9 years) of the control group without chronic leg ischaemia.
Patients with peripheral arteriosclerosis showed significantly decreased venous thiobarbituric acid reactant levels
(2.01 ± 0.37 vs 2.39 ± 0.59 μπιοΐ/ΐ in controls, ρ < 0.05). Both arterial and venous samples from patients showed
lower Cu, Zn-superoxide dismutase activities and higher glutathione peroxidase activities than controls. Venous
activities of glutathione peroxidase were significantly higher than arterial activities in both groups (patients
0.52 ± 0.18 vs 0.43 ±0.15 μkat/g Hb, ρ < 0.001, control group 0.51 ± 0.12 vs 0.39 ±0.19 μkat/g Hb, ρ < 0.01).
The trace element profile of the patients showed a highly significant decrease in magnesium levels (p < 0.001) and
increased venous copper levels (p < 0.05). No significant changes were found in zinc and selenium levels. The
results of this study show that during chronic leg ischaemia the production of free oxygen radicals at rest is well
controlled, but the activity of antioxidant enzymes seems to be impaired.
Introduction
Lipid peroxidation, i.e. alteration of polyunsaturated
fatty acids by free oxygen radicals, plays an important
role in the pathogenesis of many diseases including ath-
erosclerosis. Oxidatively modified low density lipopro-
teins (LDL) play an important role in the development
of atherosclerosis. Subendothelial oxidized LDL un-
dergoes accelerated endocytosis by macrophages via
their scavenger receptors, leading to cholesterol accu-
mulation (1, 2). For laboratory investigation, the deter-
mination of thiobarbituric acid reactants is widely used
for evaluating overall lipid peroxidation (3).
The antioxidant potential of blood is normally sufficient
to counteract the local tissue generation of free oxygen
radicals. However, in atherosclerotic diseases the activ-
ity of antioxidant enzymes and the microelement status,
which are implicated in protection against free oxygen
radicals, are significantly modified (4, 5).
The majority of research has been concentrated on acute
ischaemic/reperfusion injury of myocardium, and only a
few studies have been reported on patients with chronic
leg ischaemia (6—8). Therefore, the aim of the present
study was to investigate a possible role of lipid peroxi-
dation and some antioxidant protective mechanisms in
chronic leg ischaemia in patients with angiographically
verified peripheral arterial occlusive disease.
The amount of lipid peroxidation was assessed by thio-
barbituric acid reactant concentration. We also evaluated
the importance of Cu, Zn-superoxide dismutase1) and
glutathione peroxidase1) activities as well as serum
levels of zinc, copper, selenium and magnesium as pos-
sible effectors in protection against, or acceleration of,
the arteriosclerotic process. The analytes were deter-
mined in blood samples from the common femoral ar-
tery and vein, in order to evaluate local metabolic
changes in chronic leg ischaemia at rest.
Materials and Methods
Patients
The study included 15 patients from the Department of Surgery,
Roosevelt Hospital (10 men and 5 women) with a mean age of
57 ±1 years (mean ± SD); a total of 30 lower limbs were exam-
ined. In view of the nature of the experiment, each patient's lower
]) Eii2ymes:
Glutathione peroxidase, glutathione
ductase, EC 1.11.1.9)
Superoxide dismutase (Superoxide
EC 1.15.1.1)
Xanthine oxidase (xanthine : oxygen oxidoreductase, EC 1.1.3.22)
hydrogen-peroxide oxidore-
superoxide oxidoreductase,
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extremity was regarded as a separate clinical entity. Obliterative
arteriosclerosis of the lower limb was verified by angiography. All
patients showed diffuse arteriosclerotic lesions, predominantly in
the femoropopliteal segment. Ten lower limbs were considered as
critical leg ischaemia. patients with gangrene or diabetes mellitus
were excluded from the study. The patients had been receiving
an oral haemorheologic preparation since long before the present
investigation. Eleven patients (73%) were regular smokers at the
time of the study.
Control group
A control group was made up of 9 individuals (6 men and 3
women) from the Department of Neurosurgery, Roosevelt Hospital,
who had undergone angiographic examinations for other reasons.
The mean age of the control group was 54 ± 9 years (mean ± SD)
and a total of 18 lower limbs were examined. Peripheral arterial
occlusive disease and diabetes mellitus were absent in this group
according to clinical and laboratory investigations.
The study was approved by the local Ethics Committee and written
informed consent was obtained.
Blood sampling and sample preparation
Fasting blood samples were collected from supine patients, first
from the common femoral vein and immediately thereafter from
the common femoral artery. The patients remained in the supine
position at rest for 30 minutes before examination. Samples in the
control group were taken before the angiographic examination un-
der the same conditions. Blood was collected into 2.7 ml heparini-
sed and 2.7 ml Serum preparation tubes, both trace element-free
(Sarstedt Monovette, N mbrecht, Germany). About 2 ml of hepa-
rinised whole blood was used immediately for the enzyme determi-
nation. The remainder of the blood was then centrifuged (2000 g
for 10 min at 20 °C), and plasma or serum were removed carefully
to avoid platelets and exogenous contamination. The samples for
thiobarbituric acid reactants and trace element determination were
analysed either immediately on the same day or stored frozen at
-20 °C in Eppendorf polypropylene micro test tubes (Hamburg,
Germany) and analysed later within 5 days.
Samples Analysis
Thiobarbituric acid reactants
Thiobarbituric acid reactants were determined in plasma with a
modified fluorometric thiobarbituric acid test (9). Briefly, the
plasma sample was heated (60 minutes at 90 °C) at low pH with
thiobarbituric acid. After cooling in tap water, 2 ml of w-butanol
was added. The thiobarbituric acid reactant complex was extracted
by shaking, the phases separated by centrifugation and the n-buta-
nol layer was taken for fluorometric measurement (excitation
λ = 515 nm and emission λ = 553 nm) using a fluorescence spec-
trophotometer, model 204 (Perkin Elmer Ltd., Norwalk, USA). The
thiobarbituric acid reactant concentration was derived from a stan-
dard of 1,1,3,3-tetramethoxypropane. Results are expressed in
μιηοΙ/1. For plasma thiobarbituric acid reactant concentration < 2.5
umol/1 the intra- and inter-assay CVs were 2.9% and 4.4%, respec-
tively. For all analytes in this study, intra- and inter-assay variations
were estimated from replicate analysis in 10 different analytical
runs, using the due order one-stage ANOVA model (10). Accuracy
was measured by evaluating the analytical recovery of our manual
standard additions. Analytical recovery was 86-102% (mean 96%,
η = 8) when the final concentration of thiobarbituric acid reactants
was < 4 μηιοΐ/ΐ.
Enzyme analysis
Cu, Zn-superoxide dismutase activity was determined with Ransod,
a Superoxide dismutase kit, based on the capacity of Cu, Zn-super-
oxide dismutase to inhibit the reduction of phenyltetrazolium chlo-
ride by xanthine oxidase. Glutathione peroxidase activity was mea-
sured with Ransel, a glutathione peroxidase kit (both from Randox
Lab, Crumlin, N. Ireland) based on the modified method of Pag-
Ha & Valentine (11) using cumene hydroperoxide as a substrate.
Cu, Zn-superoxide dismutase and glutathione peroxidase assays
were performed on a Cobas Mira (Hoffmann-La Roche, Basle,
Switzerland), an automated chemistry analyser with intra- and in-
ter-assay precisions (CVs) < 2.9% and <4.2%, respectively.
Activities of both enzymes are expressed in μkat/g of haemoglobin
of whole blood. Haemoglobin concentration was determined with
a haemoglobin kit (Lachema, Brno, Czech Republic) using the cya-
nomethaemoglobin method.
Trace element analysis
Serum zinc and magnesium concentrations were determined by
flame atomic absorption using Varian Spectr AA-30 with a deute-
rium background correction. Copper and selenium concentrations
were determined with a graphite furnace technique using GTA-95
with autosample dispenser (both from Varian Techtron, Mulgrave,
Australia). For all elements except Se, the intra- and inter-assay
CVs were < 4.2% and < 5.9%, respectively. Selenium intra- and
inter-assay variations were (CVs) < 6.3% and < 9.2%, respec-
tively. Accuracy for Zn, Mg and Cu determinations was verified
by analysing the human control serum Q alitrol HSN (Merck,
Darmstadt, Germany). Analytical bias found for Zn and Mg was
< 3.8% and for copper < 5.2%. Recoveries of added Se were 92-
106% (mean 97%, n = 8) when the final concentrations were
< 1.6 μιηοΐ/ΐ.
Reagents and standards
2-Thiobarbituric acid 99% and sulphuric acid 95—97% p.a. were
obtained from Merck, Darmstadt, Germany. 1,1,3,3-Tetrame-
thoxypropane 98% was from Aldrich Chemical Co., Milwaukee,
USA. Λ-Butanol 99% and atomic absorption standard solutions for
zinc, copper, magnesium and selenium were purchased from Sigma
Chemical Co, St. Louis, USA.
Statistical analysis
Student's t-test for paired and unpaired samples and simple linear
regression analysis were used for statistical evaluation of the re-
sults. Differences were considered as significant at the ρ < 0.05
level.
Results
Results of biochemical analysis of arterial and venous
blood samples obtained from patients with chronic leg
ischaemia and from the control group are given in table 1.
Patients with peripheral arterioslcer sis showed signifih
cantly decreased venous thiobarbituric acid reactant con-
centrations (2.01 ± 0.37 vs 2.39 ± 0.59 μιηοΐ/ΐ in con-
trols, ρ < 0.05). Both arterial and venous samples from
patients had lower Cu, Zn-superoxide dismutase activi-
ties and higher glutathione peroxidase activities than
controls. Venous activities of glutathione peroxidase
were significantly higher than arterial activities in both
groups (patients 0.52 ± 0.18 vs 0.43 ±0.15 μkat/g Hb,
ρ < 0.001, control group 0.51 ± 0.12 vs 0.39 ± 0.19
μkat/g Hb, ρ < 0.01). The trace element profile of the
patients showed a highly significant decrease in magne-
sium levels (p < 0.001) and increased venous copper
levels (p < 0.05). No significant changes were found in
zinc and selenium levels. Results from simple linear re-
gression analysis are shown in table 2. Magnesium
levels in the control group showed significant corre-
lations with the levels of Cu, Zn-superoxide dismutase
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(artery r = -0.839, p < 0.001, vein r = -0.739,
p < 0.01), glutathione peroxidase (artery r = 0.623,
p < 0.05), Zn (artery r = 0.788, p < 0.001, vein
r = 0.549, p < 0.01) and Cu (artery r = 0.765,
p < 0.001, vein r = 0.572, p < 0.05). In contrast, these
correlations were not observed in patients.
Discussion
Chronic leg ischaemia constitutes, for tissues, a combi-
nation of inadequate supply of substrates and oxygen
with an insufficient efflux of toxic products.
In healthy individuals, free oxygen radical production is
controlled by antioxidative enzymes. As already re-
ported by Manso for hypoxia (12), the venous blood
levels of thiobarbituric acid reactants in our ischaemic
patients were lower than in controls. The decrease in
pO2 in venous blood may restrict the availability of oxy-
gen for free oxygen radical production. However, the
difference in thiobarbituric acid reactant concentrations
between patients and controls was not as great as would
be expected. Our results indicate that a certain amount
of thiobarbituric acid reactants can be produced during
oxygen deprivation. In the hypoxic status, free oxygen
radicals may be generated within muscle cells and by
the endothelial xanthine oxidase (12, 13).
The thiobarbituric acid test is used as the main assay for
lipid peroxidation. In recent years this assay has been
subjected to pervasive criticism on several grounds:
1) Thiobarbituric acid assay is based on the quantitative
measurement of aldehyde breakdown products of some,
but not all lipid hydroperoxides;
2) Because the thiobarbituric acid test is calibrated with
malondialdehyde the results are often expressed in ma-
londialdehyde content, although the terms "malondial-
dehyde-like material" or "thiobarbituric acid reactants"
would be more appropriate;
3) In humans, only a small fraction of lipid peroxides
can be converted into malondialdehyde and, more, ma-
londialdehyde is formed during the thiobarbituric acid
procedure from various non-lipid compounds including
DNA, carbohydrates and amino acids;
4) The thiobarbituric acid test lacks specificity, and the
assays show poor precision.
Accepting these limitations, however, rigorous control
of this simple test procedure and careful interpretation of
the results can yield useful information on lipid peroxide
production. Recently, direct determination of malondial-
dehyde with the thiobarbituric acid/HPLC technique was
recommended (14).
Tab. 1 Results of biochemical analysis of arterial and venous blood samples obtained from patients
with chronic leg ischaemia and from the control group.
Thiobarbituric acid reactants
μηιοΐ/l
Cu, Zn-superoxide dismutase
pkal/gHb
Glutathione peroxidase
μkat/g Hb
Zn μηιοΐ/ΐ
Cu μηηοΐ/ΐ
Se μηιοΐ/ΐ
Mg mmol/I
Patients
Artery (n = 15)
2.09 ±0.78
7.22 ±2.21
0.43 ±0.15 p < 0.001
12.66 ±3.73
12.50 ±2.66
0.752 ±0.191
0.773 ± 0.085°
Vein (n = 30)
2.01 ±0.37a
7.40 ±2.07
0.52 ±0.18
12.71 ±3.88
12.41 ±2.58°
0.801 ± 0.165
0.796 ±0.1 18°
Control group
Artery (n = 9)
2.35 ±0.78
7.96 ±2.49
0.39 ± 0.19 p < 0.01
12.87 ±2.44
10.76 ±3.73
0.781 ± 0.092
0.946 ±0.1 22
Vein(n = 18)
2.39 ±0.59
7.89 ± 1.98
0.51 ±0.12
13.03 ±2.35
10.46 ±3.74
0.837 ±0.166
0.921 ± 0.097
Values are means ± SD. Statistically significant differences between patients with chronic leg ischaemia
and the control group are a p < 0.05 and c p < 0.001.
Tab. 2 Results of simple linear regression for chosen quantities
Control group Patients
Cu, Zn-superoxide dismutase vs glutathione peroxidase
Cu, Zn-superoxide dismutase vs thiobarbituric acid reactants
Glutathione peroxidase vs thiobarbituric acid reactants
Cu, Zn-superoxide dismutase vs Cu, Zn
Glutathione peroxidase vs Se
art r = -0.734b
Cu art r = -0.676b
Zn art r = -0.501a
art r = 0.696b
art r = 0.582b
vein r = 0.418b
art r = 0.489a
art r = 0.74Γ
art = artery, a p < 0.05, b p < 0.01, c p < 0.001
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Like Belch (7), we found a decrease in Cu, Zn-superoxide
dismutase and an increase in glutathione peroxidase activ-
ities in patients. In the control group, Cu, Zn-superoxide
dismutase was negatively correlated with glutathione per-
oxidase, suggesting a balanced state and indicating the ca-
pacity of the blood to eliminate free oxygen radicals. By
contrast, patients showed a positive correlation between
Cu, Zn-superoxide dismutase and glutathione peroxidase.
This finding was supported by the correlation of arterial
values of Cu, Zn-superoxide dismutase and glutathione
peroxidase with thiobarbituric acid reactants in patients.
Cu, Zn-superoxide dismutase can be seen as the first line
defence against oxidative damage to membrane lipids,
while glutathione peroxidase would form a second line of
defence by detoxifying organic peroxides formed by the
molecular species not inactivated by Cu, Zn-superoxide
dismutase (15, 16). More glutathione peroxidase would
thus be necessary when less Cu, Zn-superoxide dismutase
is present, and vice versa. This could explain the negative
correlation between Cu, Zn-superoxide dismutase and
glutathione peroxidase observed in controls. These same
arguments support the existence of mechanisms regulat-
ing the activities of Cu, Zn-superoxide dismutase and glu-
tathione peroxidase according to need. The positive corre-
lation of Cu, Zn-superoxide dismutase and glutathione
peroxidase with thiobarbituric acid reactants in patients
would indicate a long term adaptation mechanism to hyp-
oxia.
The microelement profile in the serum of patients with
peripheral arteriosclerosis is characterised by a low
magnesium, low normal zinc and selenium concentra-
tions, and an elevated concentration of copper (5). In
health, the concentrations of most microelements in the
serum decrease with age (17).
The Slovak population shows generally lower selenium
levels (18). In our study, serum selenium values were
also low. Similarly, the activity of glutathione peroxi-
dase, a selenium dependent enzyme, was lower in both
examined groups compared with the normal reference
range of the manufacturer's kit (0.52-0.78 kat/g Hb
for whole blood). In the heart, selenium deficiency in-
duces an accumulation of lipid peroxides especially un-
der ischaemic conditions (19). However, we could not
demonstrate this increase of the lipid peroxides in
chronic leg ischaemia.
Increased lipid peroxidation may be a contributing
factor in the pathophysiology of low copper status. In
contrast, peripheral vascular disease results in increased
ceruloplasmin and copper concentrations in serum (5,
20). Thus the higher serum copper levels, observed in
our patients, do not stimulate the increase of lipid perox-
ide production.
Zinc and copper also control the free oxygen radical
concentration via the Fenton reaction. Zinc deficiency
may, in part, enhance lipid peroxidation in humans (21).
In controls, the serum levels of Cu and Zn correlated
negatively with whole blood levels of Cu, Zn-superox-
ide dismutase, a copper and zinc dependent enzyme.
This finding was not observed in patients, indicating im-
pairment of this antioxidant system.
Decreased Mg levels may be involVed in lipid peroxi-
dative process and are associated with atherosclerotic
disease (17). Magnesium levels were significantly
lower in patients than in controls. The correlations
between Mg and all the monitored quantities confirm
the important role played by Mg in metabolism. The
balance, however, becomes upset in permanent tissue
ischaemia.
We have postulated that arterio-venous differences re-
flect local metabolic changes. We assumed that the eval-
uation of metabolism at rest eliminates the influence of
blood flow changes in the leg, so that the measured con-
centrations should reflect the amounts of metabolites ac-
tually produced. In our study, arterio-venous differences
at rest did not mirror local changes in metabolism, as
demonstrated during exercise or in an animal model (22,
23). In both groups, the arterial and venous values for
most of the measured quantities were not significantly
different. Only glutathione peroxidase showed a signifi-
cant increase in venous blood in both groups. The fall
of pO2 in the venous circulation may induce a transient
increase of glutathione peroxidase activity as an antioxi-
dant reserve before lung oxygen reabsorption. The tran-
sient increase of glutathione peroxidase activity in ve-
nous blood may also indicate the presence of a short
term regulatory mechanism, or a cellular efflux of this
enzyme.
In conclusion, the effect of ischaemia may differ in vari-
ous parts of the body. The patients investigated showed
an inhibition of lipid peroxide production and impair-
ment of an antioxidant enzyme system. Other factors
that may favour lipid peroxidation, such as an observed
slight decrease in zinc and selenium serum levels, and
in particular a significant decrease in magnesium levels,
had no influence on lipid peroxide concentrations in
our patients.
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